Moreover, SLC25A22 serves as an essential metabolic regulator for CRC progression [30] by promoting the synthesis of aspartate-derived amino acids (asparagine) in KRAS-mutant CRC cells [31]. This evidence concerns the gene KRAS and colorectal carcinoma.